Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin

British Journal of Pharmacology

Volumn 125, Issue 4, 1998, Pages 865-873

  Stam, Wiro B ^a   Van Der Graaf, Pieter H ^b   Saxena, Pramod R ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Aorta; Atosiban; OPC 21268; Oxytocin; Rat; Small mesenteric artery; SR 49059; Vasopressin receptors

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; ARGIPRESSIN; ATOSIBAN; OXYTOCIN; RECEPTOR SUBTYPE; RELCOVAPTAN; VASOPRESSIN V1 RECEPTOR;

ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; VASODILATATION;

ANIMALS; AORTA; ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HORMONE ANTAGONISTS; INDOLES; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PIPERIDINES; PYRROLIDINES; QUINOLONES; RATS; RATS, WISTAR; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; VASOTOCIN;

EID: 0031760798     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702149     Document Type: Article

References (44)

1. ALTURA, B.M. (1975). Dose-response relationships for arginine vasopressin and synthetic analogs on three types of rat blood vessels: possible evidence for regional differences in vasopressin receptor sites within a mammal. J. Pharmacol. Exp. Ther., 193, 413-423.
2. 1-receptor assay in rat small mesenteric arteries. In The resistance arteries. Halpern, W. pp. 43-51. Totowa, New Jersey: Human Press.
3. ANOUAR, A., CLERGET, M.S., DURROUX, T., BARBERIS, C. & GERMAIN, G. (1996). Comparison of vasopressin and oxytocin receptors in the rat uterus and vascular tissue. Eur. J. Pharmacol., 308, 87-96.
4. 8]Vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists. Eur. J. Pharmacol., 285, 199-222.
5. 2-receptor antagonists on the mouse isolated stomach assay. Br. J. Pharmacol., 86, 581-587.
6. BLACK, J.W., LEFF, P., SHANKLEY, N.P. & WOOD, J. (1985b). An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br. J. Pharmacol., 84, 561-571.
7. BURRELL, L.M., PHILLIPS, P.A., ROLLS, K.A., BUXTON, B.F., JOHNSTON, C.I. & LIU, J.J. (1994). Vascular responses to vasopressin antagonists in man and rat. Clin. Sci., 87, 389-395.
8. 1 receptor antagonist (OPC-21268) in the rat. J. Endocr., 138, 259-266.
9. 1 receptor antagonist. Clin. Exp. Pharmacol. Physiol., 20, 388-391.
10. 1 receptor in the isolated human gastric artery. Life Sci., 60, PL63-68.
11. FENGER-GRON, J., MULVANY, M.J. & CHRISTENSEN, K.L. (1997). Intestinal blood flow is controlled by both feed arteries and microcirculatory resistance vessels in freely moving rats. J. Physiol., 498.1, 215-224.
12. FURCHGOTT, R.F. & VANHOUTTE, P.M. (1989). Endothelium-derived relaxing and contracting factors. FASEB J., 3, 2007-2018.
13. GARCIA-VILLALON, A.L., GARCI, J.L., FERNANDEZ, N., MONGE, L., GOMEZ, B. & DIEGUEZ, G. (1996). Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br. J. Pharmacol., 118, 1848-1854.
14. GUTKOWSKA, J., JANKOWSKI, M., LAMBERT, C., MUKADDAMDAHER, S., ZINGG, H.H. & McCANN, S. (1997). Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc. Natl. Acad. Sci. U.S.A., 94, 11704-11709.
15. HEINEMANN, A., HORINA, G., STAUBER, R.E. & PESKAR, B.A. (1998). Different receptor mediation of direct vasoconstriction and potentiation of adrenoceptor mediated pressor responses by vasopressin in the rat isolated mesentery. Br. J. Pharmacol., 123, 287P.
16. HIRASAWA, A., SHIBATA, K., KOTOSAI, K. & TSUJIMOTO, G. (1994). Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor. Biochem. Biophys. Res. Commun., 203, 72-79.
17. JENKINSON, D.H., BARNARD, E.A., HOYER, D., HUMPHREY, P.A., LEFF, P. & SHANKLEY, N.P. (1995). International union of pharmacology committee on receptor nomenclature and drug classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. Rev., 47, 255-266.
18. JOVANOVIC, A., GRBOVIC, L., ZIKIC, I. & TULIC, I. (1995). Characterization of arginine vasopressin actions in human uterine artery: lack of role of the vascular endothelium. Br. J. Pharmacol., 115, 1295-1301.
19. JOVANOVIC, A., JOVANOVIC, S. & GRBOVIC, L. (1997). Effect of oxytocin as a partial agonist at vasoconstrictor vasopressin receptors on the human isolated uterine artery. Br. J. Pharmacol., 121, 1468-1474.
20. KATUSIC, Z.S., SHEPHERD, J.T. & VANHOUTTE, P.M. (1984). Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ. Res., 55, 575-579.
21. LIU, J.J., PHILLIPS, P.A., BURRELL, L.M., BUXTON, B.B. & JOHNSTON, C.I. (1994). Human internal mammary artery responses to non-peptide vasopressin antagonists. Clin. Exp. Pharmacol. Physiol., 21, 121-124.
22. LLUCH, S., GONDE, M.V., DIEGUEZ, G., LOPEZ, A.L., GONZALES, M.C., ESTRADA, C. & GOMEZ, B. (1984). Evidence for the direct effect of vasopressin on human and goat cerebral arteries. J. Pharmacol. Exp. Ther., 228, 749-755.
23. MANNING, M. & SAWYER, W.H. (1984). Design and uses of selective agonistic and antagonistic analogs of the neuropeptides oxytocin and vasopressin. Trends Neurosci., 7, 6-9.
24. MANNING, M. & SAWYER, W.H. (1989). Discovery, development, and some uses of vasopressin and oxytocin antagonists. J. Lab. Clin. Med., 114, 617-632.
25. MARTIN, P.L. (1989). Operational analysis of α-adrenoceptors on the rat and rabbit aorta. Ph.D. Thesis, University of London.
26. MARTIN DE AGUILERA, E., VILA, J.M., IRURZUN, A., MARTINEZ, M.C., MARTINEZ CUESTA, M.A. & LLUCH, S. (1990). Endothelium-independent contractions of human cerebral arteries in response to vasopressin. Stroke, 21, 1689-1693.
27. MARTINEZ, M.C., ALDASORS, M., VILA, J.M., MEDINA, P. & LLUCH, S. (1994a). Responses to vasopressin and desmopressin of human cerebral arteries. J. Pharmacol. Exp. Ther., 270, 622-627.
28. MARTINEZ, M.C., VILA, J.M., ALDASORO, M., MEDINA, P., FLOR, B. & LLUCH, S. (1994b). Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin. Br. J. Pharmacol., 113, 419-424.
29. MEDINA, P., MARTINEZ, M.C., ALDASORO, M., VILA, J.M., CHUAN, P. & LLUCH, S. (1996). Contractile responses of human deferential artery and vas deferens to vasopressin. Eur. J. Pharmacol., 300, 221-225.
30. MILLETTE, E. & LAMONTAGNE, D. (1996). Endothelium-dependent and NO-mediated desensitization to vasopressin in rat aorta. Br. J. Pharmacol., 119, 899-904.
31. MULVANY, M.J. & HALPERN, W. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res., 41, 19-26.
32. MYERS, P.R.., BANITT, P.F., GUERRA, R. & HARRISON, D.G. (1989). Characteristics of canine coronary resistance arteries: importance of endothelium. Am. J. Physiol., 257, H603-H610.
33. 1 receptor of rat, rhesus and human tissues. Life Sci., 50, 1953-1958.
34. PRENTICE, D.J. & HOURANI, S.M.O. (1997). Information in agonist curve shape for receptor classification. Ann. N.Y. Acad. Sci., 812, 234-235.
35. RUSS, R.D. & WALKER, B.R. (1992). Role of nitric oxide in vasopressinergic pulmonary vasodilatation. Am. J. Physiol., 262, H743-H747.
36. 1a antagonist, to rat and human liver membranes. Biochem. Biophys. Res. Commun., 199, 353-360.
37. 1a receptors. J. Clin. Invest., 92, 224-231.
38. STAM, W.B, VAN DER GRAAF, P.H. & SAXENA, P.R. (1996). Characterization of the receptors mediating the contraction of rat isolated small mesenteric artery to arginine vasopressin and oxytocin. Br. J. Pharmacol., 119, 90P.
39. SUZUKI, Y., SATOH, S., OYAMA, H., TAKAYASU, M., SHIBUYA, M. & SUGITA, K. (1994). Vasopressin mediated vasodilation of cerebral arteries. J. Auton. Nerv. Syst., 49, S129-S132.
40. 1adrenoceptor antagonists in rat aorta. Br. J. Pharmacol., 118, 299-310.
41. 1-adrenoceptors. Br. J. Pharmacol., 115, 125P.
42. WALKER, B.R., HAYNES, J., WANG, H.L. & VOELKEL, N.F. (1989). Vasopressin-induced pulmonary vasodilation in rats. Am. J. Physiol., 257, H415-H422.
43. YAMAMURA, Y., OGAWA, H., CHIHARA, T., KONDO, K., ONOGAWA, T., NAKAMURA, S., MORI, T., TOMINAGA, M. & YABUUCHI, Y. (1991). OPC-21268, an orally effective, nonpeptide vasopressin VI receptor antagonist. Science, 252, 572-574.
44. 2+ signalling in a human vascular smooth muscle cell line. Br. J. Pharmacol., 117, 799-804.